Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
Zefei Jiang(Chinese PLA General Hospital), Quchang Ouyang(Central South University), Tao Sun(Liaoning Cancer Hospital & Institute), Qingyuan Zhang(Harbin Medical University), Yuee Teng(First Hospital of China Medical University), Jiuwei Cui(Jilin University), Haibo Wang(Qingdao University), Yongmei Yin(Jiangsu Province Hospital), Xiaojia Wang(Zhejiang Cancer Hospital), Xin Zhou(Chongqing University), Yongsheng Wang(Shandong Tumor Hospital), Gang Sun(Xinjiang Medical University), Jingfen Wang, Lili Zhang(Jiangsu Cancer Hospital), Jin Yang(People's Liberation Army No. 150 Hospital), Jun Qian(First Affiliated Hospital of Bengbu Medical College), Min Yan(Henan Cancer Hospital), Xinlan Liu(Ningxia Medical University), Tienan Yi(Xiangyang Central Hospital), Ying Cheng(Jilin Province Tumor Hospital), Man Li(Dalian Medical University), Aimin Zang(Affiliated Hospital of Hebei University), Shusen Wang(Sun Yat-sen University), Chuan Wang(Fujian Medical University), Xinhong Wu(Jiangnan University), Jing Cheng(Union Hospital), Hui Li(Sichuan Cancer Hospital), Ying Lin(Sun Yat-sen University), Cuizhi Geng(Hebei Medical University), Kangsheng Gu(Anhui Medical University), Chunwei Xie, Huihua Xiong(Tongji Hospital), Xiaohong Wu(Jiangnan University), Junlan Yang(People's Liberation Army No. 150 Hospital), Qingshan Li(Chengde Medical University), Yiding Chen(Second Affiliated Hospital of Zhejiang University), Fanfan Li(Anhui University), Anqin Zhang, Yongqiang Zhang(Beijing Hospital), Yudong Wu(Jiangxi Provincial Cancer Hospital), Jianyun Nie(Kunming Medical University), Qiang Liu(Sun Yat-sen University), Kun Wang(Guangdong Provincial People's Hospital), Xueli Mo(Peking University Shougang Hospital), Lilin Chen(First Affiliated Hospital of Xiamen University), Yueyin Pan(Anhui Provincial Hospital), Peifen Fu(First Affiliated Hospital Zhejiang University), Helong Zhang(Chinese People's Liberation Army), Danmei Pang(First People's Hospital of Foshan), Yuan Sheng(Second Military Medical University), Yunwei Han(Affiliated Hospital of Southwest Medical University), Hongxia Wang(Qingdao University), Shundong Cang(Henan Provincial People's Hospital), Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan(BioReliance (United States))
Cited by 107
Abstract
Related Papers
Immune-related adverse events of checkpoint inhibitors
Manuel Ramos‐Casals, Julie R. Brahmer, Margaret K. Callahan et al.|Nature Reviews Disease Primers|2020|1.4k